ROCKVILLE, MdTwo cancer-related topics are among four new
evaluations the Agency for Health Care Policy and Research (AHCPR)
has asked the U.S. Preventive Services Task Force to make. The task
force is an independent panel of preventive health experts that
evaluates the effectiveness of a wide range of clinical preventive services.
The AHCPR has asked that the group address chemoprophylaxis for
breast cancer, including use of tamoxifen (Nolvadex) and related
drugs, and to evaluate vitamin supplementation as a means of
preventing cancer and heart disease. The Agency also asked the panel
to assess screening for bacterial vaginosis in pregnancy and
developmental screening in children.
Among the eight previously studied topics for which AHCPR wants new
evaluations are skin cancer screening and postmenopausal hormone therapy.